• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Up 0.17%

    Merrimack Pharmaceuticals, Inc. (MACK)

    -NasdaqGM
    3.01 Down 0.05(1.63%) Feb 24, 4:00PM EST
    |After Hours : 3.01 0.00 (0.00%) Feb 24, 5:22PM EST
    Prev Close:3.06
    Open:3.05
    Bid:3.00 x 500
    Ask:3.03 x 10000
    1y Target Est:9.00
    Beta:2.40062
    Next Earnings Date: 1-Mar-17MACK Earnings announcement
    Day's Range:3.00 - 3.09
    52wk Range:2.83 - 9.02
    Volume:1,324,549
    Avg Vol (3m):3,593,020
    Market Cap:392.21M
    P/E (ttm):N/A
    EPS (ttm):-1.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    MACKDown 1.63%392.21M
    THLDUp 9.02%43.24M
    1 0.00%N/A
    IMMUDown 0.20%518.73M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):3.80
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.16
    Quarterly EPS Est (Dec-16) :-0.21
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-0.47

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer primarily in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback